SlideShare a Scribd company logo
1 of 72
Download to read offline
HEALTH
(This is an expanded version of a talk given at the
Fukushima:The Next ThreeYears symposium in
Tokyo, March 15, 2014)
Azby Brown, SAFECAST
v06
Lots of potential health
consequences =
Lots of concerns
Thyroid cancer, leukemia, other cancer,
birth effects, other disease, DNA mutations?
Food, water, playing outside, pregnancy?
Legitimate grievances
Is the Gov’t doing everything it can to
ensure our health and safety?
Is justice being done, in terms of
compensation, accountability, etc?
How can people be compensated for such
massive damage to their lives anyway?
Uncertainty
It is almost always impossible to say
conclusively how many people will get sick.
Estimates are almost always based on
incomplete information.
Uncertainty
But even with good data we’re usually left
with no more than a “range of probability.”
--Depending on the type of data and its
quality, uncertainty might be small i.e., +/- 10%.
--In our current situation, it’s rarely less than a
factor of 2, i.e. +/- 2x
--In many cases, it’s an order of magnitude or
more, i.e. +/-10x. This is actually normal.
Uncertainty
• So, expert A says “Probably 2.5% will get sick.”
• Expert B says,“Probably 5% will get sick.”
• Expert B’s estimate is double expert A’s.
• But actually they agree closely.
“Essentially, all models are wrong, but
some are useful.”
“Remember that all models are wrong;
the practical question is how wrong do
they have to be to not be useful.”
George E.P. Box
MODELS:
immediate
(acute)
effects
long-term
(stochastic)
effects
begin to see ARS
50% fatal in 1 month
fatal in weeks
1 Sv=1000 mSv: increased risk of fatal cancer 5%
(but good arguments for assuming 10%)
good (but not conclusive)
evidence for increased leukemia
0
mSv
20 100 1000 5000 10,000
increased cancer % is clearuse LNT
immediate
(acute)
effects
long-term
(stochastic)
effects
begin to see ARS
50% fatal in 1 month
fatal in weeks
1 Sv=1000 mSv: increased risk of fatal cancer 5%
(but good arguments for assuming 10%)
good (but not conclusive)
evidence for increased leukemia
0
mSv
20 100 1000 5000 10,000
increased cancer % is clearuse LNT
Best Fukushima
dose estimates
Dumb Luck.
The wind usually blew the plume out to sea.
That’s the main reason the doses are so low.
About “dose” and “risk”
5% per Sv?
10% per Sv?
Public health risk:
Increased fatal cancer risk:
Individual risk:
100mSv = 0.5 -1%
10mSv= 0.05-0.1%
1mSv= 0.005- 0.01%
100mSv = 5-10 per 1000 pers
10mSv = 5-10 per 10,000 pers
1mSv = 5-10 per 100,000 pers
Current assumption:
Some evidence suggests:
Measurement (“in-vivo”)
Based on WBC, blood tests, personal
dosimetry, etc.
Estimates (reconstruction, simulation)
Based on environmental dose rates,
models, food intake surveys, etc.
Epidemiology (past experience, statistics)
Based on historical statistics, etc.
Less uncertainty
More uncertainty
It’s very important to have good
in-vivo measurements!
Some things we’ll never
know for sure:
Initial doses, i.e March-May, 2011
Not enough in-vivo screening was done!
(But maybe enough to make acceptable estimates)
Psycho-social effects
Very real, very serious already
Stress, PTSD, depression, sleep disorders,
chronic anxiety, physical symptoms, family
problems, breakdown of community
support, etc.
Already 1,660 “disaster-related deaths” in Fukushima!
(i.e. life shortened by stress of evacuation)
Thyroid Cancer
Fukushima Prefecture Health Survey
thyroid screening program
Total screened to date (age 0-18): 269,354
(out of 333,403 planned in 1st round of screening)
Anomalies (nodules/cysts found): 46.6%
Cancers found or suspected: 74 cases (0.027%)
What does this mean?
Opinions of outside experts:
Sir Dillwyn Williams, Cambridge Univ. :
(A leading endocrinologist who, with, Keith Baverstock,
made a crucial effort to get thyroid cancer outbreak
acknowledged after Chernobyl)
--The observed incidence of any cancer in a population
depends on the method used to look for it.
--Any systematic survey will find more cases than the normal
system of waiting for the patient or relatives to notice
something.
--The more sensitive the screening system the larger number
of cases will be found.
--This is particularly true for slow growing cancers like
thyroid, where it takes a considerable time for the earliest
cancer to grow from just a few cells to a detectable lump.
He points out that:
(personal communication)
Sir Dillwyn Williams, cont’d
- The chance that the current apparent increase in thyroid
tumours is due to radiation exposure is very low.
- The tumors pose little health threat.
- High-resolution ultrasound screening is a new technique, and
reveals many harmless anomalies.
- Not enough time has passed for radiogenic tumors to appear.
- The doses are uncertain, but appear too low in nearly all areas
to cause detectable increase.
- Milk and other contaminated food was stopped soon.
- Japanese children have sufficient iodine in their diet compared
to Chernobyl.
- This study will show the normal baseline prevalence of thyroid
tumors.
- It’s too early to know for sure how many new cases will arise
(incidence), we will have to wait at least 4 years.
Initial opinion in Feb., 2012:
(personal communication)
As more data became available, similar opinions expressed by
Baverstock, Demidchik,Tronko, Ivanov, Jacob, and other
leading experts:
Fukushima thyroid cancers, so far (Feb. 2014):
- Still to soon to be caused by radiation.
- Children under 5 would be first, but none so far.
- No clear correlation with dose levels
“It’s still too early to know.”
But we can expect some increase !
At this point, strong consensus.
31 December 2013)
2.2.1 Suspicious or malignant cases by age as of 11 March 2011
2.2.2 Suspicious or malignant cases by age as of the date of confirmatory examination
0
2
4
6
8
10
12
14
16
18
20
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Female
Male
Number
Age
Number
Fukushima Health Management Survey, Reported on 7 February 2014
None under 5yrs
“Dissenting” viewpoint: Tsuda, Hamaoka, etc.:
- Rate seems to be increasing 2011-2013.
- Maybe there is a correlation with dose levels.
- Maybe Chernobyl tumors would have been detected.
earlier if there had been widespread ultrasound screening.
- Maybe Fukushima dosimetry is very wrong.
- Maybe Fukushima Pref Health Survey is untrustworthy.
The evidence is not strong,
but these ideas need to be considered and tested!
Good scientists never say “never” !
Results of thyroid comparison survey
Dates of study: Nov, 2012 - March 2013
4365 children in Aomori Pref., Yamanashi Pref., Nagasaki Pref.
Age 3-18 years
Anomaly detection rate: 56.88%
(Detection rate in Fukushima: 43.6%)
Source: Japan Environ. Ministry: http://www.env.go.jp/press/press.php?serial=16419
More anomalies outside Fukushima
The results are similar, but the surveys are not perfectly
comparable, and the size of the cohort is statistically very
small; one more cancer case would double the apparent rate.
Preliminary report March, 2013;
Detailed report, Hayashida, et al, Dec., 2013
UPDATE: March 28, 2014: Results of followup examinations:
--31 children had followup exams.
--1 cancer case found or suspected.
--The rate so far is 0.022% ; the rate in Fukushima is 0.027%
(but actually quite similar)
What do we know about the thyroid doses?
Unfortunately, not many timely in-vivo measurements,
and it’s difficult to be confident in the results:
Hosokawa, et al: 1080 children in Iitate, Kawamata, Iwaki:
avg 12mSv, max 42 mSv
Tokonami, et al: 62 pers 0-83 yrs:
Children: median 4.2 mSv, max 23 mSv
Adults: median 3.5 mSv, max 33 mSv
(About 400,000 people were screened a short
time after the Chernobyl disaster!)
Also some data from US military, overseas embassies.
These match the most thorough independent dose
reconstruction for Iitate (Imanaka):
--1yr old: min 14mSv, avg 24mSv, max 55mSv
Though these reconstructions match well,
the initial doses are still uncertain.
What do we know about the thyroid doses?
WHO estimates, 2013:
--Iitate: 1yr old: 73mSv
--Namie:	

1yr old: 122mSv
(Assumed outdoors
24 hrs/day, and ate
contaminated food)
UNSCEAR, 2013:
--All Fukushima: 1yr old: avg 15-83mSv
--Iitate: 1yr old: avg 56mSv
--Maximum estimated dose: 150 mSv
!"#"$%&%
!" '%()*)
+,*&"#*-
#$%&'
.%/(&"0000000
() '%()*)
+,*&"#*-
)*"%&'
12"345"6"
+,) '%()*)
+,*&"#*-
,*)%&'
142"2*0,477"#*00000
+-!".'%()*)
+,*&"#*- +#%&'
Imanaka, 2013
0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150
mSv
WHO:
UNSCEAR:
children
children
Iitate 1yr old
Imanaka:
Iitate 1yr old
!"#$#%&$'(&)*+&,-.
All Fukushima 1yr olds
Namie1yr old
adults
/01023"4$&#3*+,".&.,2%25&)2#&*%$+5&6%2#&%2#"4$#%2
78$"+-*&9-,2%&$(+%%4%:#5&4$;&)<=&4>'?
$'(@4%$:
7:,&$'(@4%$:&("'%:?
!:A'"',&4%$20+%4%:#2
B,2%&
+%9,:2#+09#",:2
7+$:(%&,8&$'%+$(%2&,8&$--&2%##-%4%:#2?
7+$:(%&,8&0:9%+#$":#*?
Hosokawa, et al:
Tokonami, et al:
Rayon-average thyroid doses of children and
adolescents (as of time of the Chernobyl accident)
in Belarus, Russia and Ukraine
(Ivanov, Kenigsberg, Likhtarev, Balonov, 2006)
All rights reserved
>650 mGy
150-650 mGy
30-150 mGy
10-30 mGy
Quite a few over 1 Gy!(1Gy≈1Sv)
Chernobyl thyroid doses: up to 1000mSv +
Fukushima thyroid dose estimates
(But some cancers expected at low dose range)
1000 200 300 400 500 600 700 800 900 1000
mSv
0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150
mSv
WHO:
UNSCEAR:
children
children
Iitate 1yr old
Imanaka:
Iitate 1yr old
!"#$#%&$'(&)*+&,-.
All Fukushima 1yr olds
Namie1yr old
adults
/01023"4$&#3*+,".&.,2%25&)2#&*%$+5&6%2#&%2#"4$#%2
78$"+-*&9-,2%&$(+%%4%:#5&4$;&)<=&4>'?
$'(@4%$:
7:,&$'(@4%$:&("'%:?
!:A'"',&4%$20+%4%:#2
B,2%&
+%9,:2#+09#",:2
7+$:(%&,8&$'%+$(%2&,8&$--&2%##-%4%:#2?
7+$:(%&,8&0:9%+#$":#*?
Hosokawa, et al:
Tokonami, et al:
How much thyroid cancer are we likely to see?
One reasonable estimate so far:
Many uncertainties, not conclusive!
Jacob, et al, 2014:
--New baseline (normal prevalence) will be about 7x higher
than previously believed, i.e., 2.2%.
--Based on the estimated percentages, in the next 50 years,
with 330,000 people being studied, about 7300 will be
diagnosed with thyroid cancer.
--Only about 300-1000 of these will be new cases (incidence)
due to radiation.
--Most of these would not cause health problems if not
discovered (i.e. they would be “subclinical”).
Pros and Cons of thyroid screening
according to Williams:
Pros:
--Screening reassures the great majority of the population
that they do not have a cancer.
--Resection of screen detected tumors in children may
prevent the development of ‘more difficult to treat’ cancers
at a later age.
Cons:
--Screening raises the level of concern in the population
generally.
--Some, possibly many, of the operations may have been for
‘technical cancers’ which would not have progressed.
--Operations carry a risk of complications, even though these
are extremely rare in skilled hands.
(personal communication)
Will the Fukushima thyroid screening
program create more health problems
than it solves?
“It was appropriate to set up the screening program
for those exposed to Fukushima fallout; on balance I
believe it will benefit the population as well as
providing information that will be very important in
the event of another accident. Open discussions with
the public to consider all the results and decide on the
appropriate future course of action are extremely
important.”
Williams suggests that:
(personal communication)
So far, most experts generally agree with
the interpretation of thyroid screening
results stated by the gov’t, but many
people do not believe them.
Legitimate grievances
--Very poor communication, gov’t did not
manage expectations.
-- Misleading statements by Dr.Yamashita
(“No risk below 100 mSv”).
-- Many people feel the emphasis has been on
“collecting data” rather than on providing
“health care.”
What can be done to improve the
credibility of health screening?
--Involve independent, 3rd-party groups, individuals, in
setting study parameters.
--Involve independent monitors for studies
themselves, and analysis of results.
--Include “dissenters” in all important conferences,
meetings.
Improve transparency!
The problems that have arisen concerning this thyroid
screening program should cause us to re-examine
how such programs can best be implemented. 
--Screening should be restricted to those under age
14 at exposure.
--Should be limited to areas with estimated average
infant thyroid doses of more than 10mGy.
--Screening should be offered on an individual basis,
with an explanation of the risks and benefits.
--Resection should continue to be advised for
screening-detected cancers in children as we cannot
currently distinguish those that will progress from
those that will not. (personal communication)
Williams' provisional suggestions include:
Other screening, monitoring
Internal contamination screening done using
whole body counters (WBC)
--Fukushima Prefecture:
Results very incompletely reported!
--Local governments (Minamisoma, Hirata, Soma, etc):
Often most complete, accurate surveys
--NPOs (CRMS, others):
Wide range in quality, completeness.
But basically, results are similar
WBC Screening program administered by
Fukushima Prefecture
Total screened to date
Period ending Jan., 2014
Fukushima Prefecture Internal Contamination Screening (WBC)
Total screened this period
Below 1mSv/yr (99%)
1mSv/yr
2 mSv/yr
3 mSv/yr
-- No distribution by Bq/body is given! (But data probably exists)
-- No information given about % which were below detection level (ND)
-- People were not weighed, so it will be impossible to know distributions by Bq/kg!
Over 99% less than 1mSv to date
WBC Screening programs administered
by Municipal Governments
Since 2011, municipal governments such as
Minamisoma and Hirata have taken the lead in
providing well-planned and well-run WBC screening
programs, under the guidance of Dr. Ryugo Hayano
and Dr. Masaharu Tsubokura of Tokyo University.
Their results are also the most completely and
informatively published, and have withstood
repeated peer-review. Gradually other local
governments, such as Soma, Iwaki, and
Kawachimura, have begun to adopt similar standards.
WBC Screening programs administered
by Municipal Governments
Among the important features of these surveys are:
--Repeated testing of residents to assess changes over
time and effectiveness of interventions.
--Families measured together whenever possible.
--One-to-one counseling after tests.
--Development of new technologies for accurately
measuring infants and small children (“BabyScan”).
--Clear demographic breakdowns of results by age, gender,
etc..
--Examine correlations between sources of food, drinking
water etc.. and internal contamination levels.
--Excellent graphs and visualizations, as well as internet
blogs to explain results.
In late 2011, almost 40% of children in Minamisoma had
internal contamination above a detection limit of 250 Bq/
body.Their initial doses shortly after the accident can only
be estimated because WBC devices were not available.
The detection rate declined throughout 2012, and
effectively reached zero (though a 20kg child could
still have as much as 12 Bq/kg and not be detected)
By late 2013, largely due to effective counseling
about food sources, the detection rate for adults
also approached zero.
MINAMISOMA CITY, April-Sept 2013
WBC results for adults (n=5810)
(Canberra FastScan)
Cs137, DL= 250 Bq/body
Source: Minamisoma Municipal Hospital
persons
Cs, Bq/kg
ND=98%
Over 20Bq/kg=0.04%
MINAMISOMA CITY, April-Sept 2013
WBC results for children (n=3390)
(Canberra FastScan)
Cs137, DL= 250 Bq/body
Source: Minamisoma City
persons
Cs, Bq/kg
ND=99.9%
Over 20Bq/kg=0.0%
Late 2013, detection rates in children remained
effectively zero.
Detection rates for both adults and children in
Minamisoma are basically zero at present, but keeping them
low will require continual monitoring and counseling.
%detected
Adults
Children
Minamisoma: Monthly Cs detection rates,
2011-2013
Source: Minamisoma City
While detection rates have declined overall, 33 people who
were “ND” at the 1st screening showed internal Cs at the
second, and 22 had Cs at both screenings despite counseling.
All are elderly who find it difficult to change their eating habits.
Cs137 ; 2380 pers total
Minamisoma: Changes observed in successive
WBC screenings
1st screening 2nd screening
Cs137
DETECTED
Cs137 NOT
DETECTED
No. of pers.
Source: Minamisoma City
The results in Hirata City are similar. Detection rates
were low overall in late 2011- early 2012.
The detection rate for children during the same
period was about 1%. This trend has continued.
(Again, a 20kg child could have as much as 12 Bq/kg
and not be detected.)
Results have been consistent in most municipalities
with similar screening and counseling programs.
These municipalities usually provide useful breakdowns
to help inform people which groups have the highest risk.
WBC Screening programs
administered by citizens’ groups
Independent WBC screening report
NPO CRMS Fukushima, Jan. 2014
Bq/kg
Period Oct. 2011 - Dec. 2013
Over 80% ND
Very few over 10Bq/kg
(But detection level varied
and is sometimes unclear)
n= 5042 persons
How do these results compare with
the experience after Chernobyl?
R
2929
Zvnova et al.
Radiation Protection Dosimetry
2000
Minenko et.al
Health Physics 2006
100,000
Bq/body
300,000
Bq/body
Low average
levels after
several years:
10,000-20,000
Bq/body
In most areas of Chernobyl, internal contamination was many
times higher than what’s been found so far in Fukushima.
Average internal contamination was between 20-40 Bq/kg
10-20 years after Chernobyl accident!
(So far in Fukushima, very few people have been found
with more than 10 Bq/kg)
Avg.
range
Though their reliability and transparency
differ, prefectural, municipal, and
independent tests all indicate that internal
contamination of Fukushima residents is
many times lower than in Chernobyl.
(peak levels as much as 1 order of
magnitude lower, avg. levels 2 orders of
magnitude lower)
Food screening results, both official and
independent, reinforce this conclusion.
Nevertheless,“outliers” with higher
contamination levels are still found.
Strongest critique of WBC testing:
--Lower levels can be detected by urine tests,
WBC can’t detect Sr90, etc.
Counter critique:
--Urine tests error-prone, difficult to collect,
unsuitable for mass screening. Sr90 doses can be
estimated from known ratios.
WBC alone is inadequate to give “clean bill of
health.” Regular health checks of many types
are needed.
WBC can reliably show whether internal doses
are greater than the 0.01 - 0.1mSv/year range.
It will never be possible to have a perfect
assurance of “no negative health effects” no
matter what kind of testing is done.
This is true always, even without radiation!
Legitimate grievances
People have a right to uncontaminated food;
a right to demand 0 Bq/body from cesium.
The environment and farmland will be
contaminated for decades; will it really be
possible to continue adequate food and internal
contamination screening the whole time?
!"#$%&"'(")*+,-(*+)./,0,1+&2*+,033(44,53$("3(,5&6%3(!"##"$!! %&&'())***+,%-./0123+1,&)4.1&,1&)5)5)6
only hope would have been time, the time it would take
for the natural elimination of 137Cs from the ecosystem.
And time is not an ally. While the half-life of 137Cs in ag-
ricultural products is 2.8–5.6 years, it is approximately 10
years for berries and 20 years for mushrooms [11]. Fes-
enko, et al.[12] studied twenty-seven rural settlements to
assess the effectiveness of countermeasures. They ob-
served an initial decrease of up to 40% of doses with a
gradual diminution of effect over time.
was accompanied by high unemployment and economic
hardship, led to a reversion to traditional diets. People
were forced to once again consume more locally produced
food as well as "free" natural foods from the forests
(mushrooms, berries, wild game, etc.). Moreover, after a
relatively short period of time, it is likely that people be-
came indifferent to warnings of the possible harm from
radiation and to recommendations about the consump-
tion of these foods. The influence of these factors is espe-
Figure 3
Dynamics of annual effective doses of internal exposure (Dint) due to 137Cs ingestion in Rokitnovsky Rayon and selected vil-
lage, Rivno Oblast, Ukraine by year from Whole Body Count (WBC) data
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
years
AnnualdoseDint,mSv
Rokitnovsky rayon
Perehodichi
Vezhytsia
St. Selo
Drozdyn
After Chernobyl, internal doses decreased until 1990-91,
then increased again as food screening was cut back.
This is probably the greatest future risk for Fukushima
residents in terms of internal contamination.
External Exposures
Individual exposures can be assessed by giving each
person a personal dosimeter (“glass badge”)
--Virtually every municipality in Fukushima has
done many glass badge surveys since 2011,
involving large proportions of the population.
--Results consistently show actual received
doses to be much lower than estimates based
on environmental dose rates and models
(usually half or less).
Again, inconsistent technically and in how reported;
no independent oversight.
Personal dosimetry (glass badge)
ガラスバッジの結果 Glass badge results, 2011
福島市 伊達市
二本松市 郡山市
南相馬市 相馬市
注:各市HP掲載データをもとに,1年分に変換
1mSv/y 1mSv/y
Data from thousands of individuals from many towns in 2011 showed
that the majority of external exposures were already under 2 mSv/yr.
(data from individual towns, graphed by R. Hayano)
Fukushima City “glass badge” results, 2011
Fukushima City“glass badge”results, 2011
51% less than
1mSv/yr
36,767 persons totalDistribution of yearly exposure estimates
yearly exposure (mSv/yr)
Data from Fukushima City Gov’t
Doses measured for 3 months,
extrapolated to 1 year.
20 mSv/yr level
no.ofpers
36,767 children and pregnant women living in Fukushima City
were given personal dosimeters in Oct-Dec. 2011. Less than half
had additional external exposures over 1mSv/yr. A few children
receiving doses far above average, and the causes, were also
identified. (In most cases the highest dose records were from
people who left their badges outdoors for long periods, or
allowed them to go through an airport Xray machine.)
Fukushima City “glass badge” results, 2012
16,223 children under middle-school age were again given
glass badges to wear from Nov. 2012 to Jan. 2013. Results
showed that 88.7% had additional exposures below 1mSv/yr,
a sharp decline in doses compared to the previous year.
Distribution of yearly external exposure estimates 16,223 persons total
Data from Fukushima City Gov’t
88.7% less than
1mSv/yr
yearly exposure (mSv/yr)
Doses measured for 3 months,
extrapolated to 1 year.
no.ofpers
The doses showed a modest decline the following year, based
on data from 10,100 children given glass badges from Sept. to
Nov., 2013. Of these, 93.48% had additional exposures below
1mSv/yr, and no child received an exposure above 5mSv/yr.
Fukushima City “glass badge” results, 2013
Distribution of yearly exposure estimates 10,100 persons total
Data from Fukushima City Gov’t
93.48% less than
1mSv/yr
yearly exposure (mSv/yr)
Doses measured for 3 months,
extrapolated to 1 year.
20 mSv, the level not to
be exceeded according
to ICRP 1990
no.ofpers
!
"
#
$
%
&
0.0 0.5 1.0 1.5
!"#$%&#'!($')*+#',%-#( ."/0)'
'()*+,#-,'.**/0)+1.2,3/+4//2,51*,6.7/,8)+/,)29,522:)0,5991+1.2)0,;<=.7:*/,6.7/,,
>,)+,)00,)?/7,@'''
ABCDEFG,
500,5?/7,
;7+1B)+/9,H1?:*/,
522:)0,,
5991+1.2)0,,
;<=.7:*/,,
6.7/,
,
$
%
&
,
'()*+,$-,'.**/0)+1.2,3/+4//2,51*,6.7/,8)+/,)29,522:)0,)991+1.2)0,/<=.7:*/,9.7/,
>,5?/,!I"&,@,
;7+1B)+/9,H1?:*/,
522:)0,,
5991+1.2)0,,
;<=.7:*/,,
Date City Glass Badge Results
52,783 pers, July 2012- June 2013
(Based on environmental dose rate)
(Actual dosimetry)
--Results show that 66% of residents’ additional external
exposure is less than 1 mSv/yr
--94% are less than 2 mSv/yr
--76 persons are are over 5 mSv/yr
--No child’s dose exceeded 4 mSv/yr
(Data from Date City Govt)
Personal dosimeters are available which can
provide a good record of how exposures
change from hour-to-hour. This is very
useful for identifying the locations where
the highest exposures are received, so
decontamination can be effectively targeted
and residents can avoid those locations.
This requires people to sit down and counsel
every resident, but unfortunately there are not
enough staff for this at present!
CONCLUSIONS
In conclusion, citizens have many legitimate
grievances about health testing programs, and
independent oversight is still lacking. Lack of trust
causes people to doubt even reliable data and
conclusions.The health risks from the Fukushima
NPP accident will never be zero.
Nevertheless the best screening and research to
date suggest that an outbreak of radiation-induced
thyroid cancer is unlikely, and that additional
internal and external doses can be kept below
1mSv/yr for the vast majority of the population.
This may not be “safe enough” in the eyes of
many citizens, but it is realistic.
To achieve and maintain even this, however,
will require a long-term commitment on the
part of the government to conscientious, well
managed monitoring of the environment,
food, and health.
If past experience is any guide, we can’t
assume that this will happen. Citizens should
continue their efforts to gather and share
information, and to press for independent
oversight where needed.
END

More Related Content

What's hot

Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...
Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...
Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...UC San Diego AntiViral Research Center
 
Shorter anogenital distance predicts poorer semen quality in young men in NY ...
Shorter anogenital distance predicts poorer semen quality in young men in NY ...Shorter anogenital distance predicts poorer semen quality in young men in NY ...
Shorter anogenital distance predicts poorer semen quality in young men in NY ...ricguer
 
Measuring effectiveness of the cervical cancer vaccine in an Australian setti...
Measuring effectiveness of the cervical cancer vaccine in an Australian setti...Measuring effectiveness of the cervical cancer vaccine in an Australian setti...
Measuring effectiveness of the cervical cancer vaccine in an Australian setti...Enrique Moreno Gonzalez
 
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...Lifecare Centre
 
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...iosrjce
 
National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)
National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)
National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)Daric Snyder
 
Women's Understanding of the term 'Pap Smear'
Women's Understanding of the term 'Pap Smear'Women's Understanding of the term 'Pap Smear'
Women's Understanding of the term 'Pap Smear'David Howard
 
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain Lifecare Centre
 
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Meningitis Research Foundation
 
Acute Leukemia Initial Presentation as Acute Appendicitis - Case Report
Acute Leukemia Initial Presentation as Acute Appendicitis - Case ReportAcute Leukemia Initial Presentation as Acute Appendicitis - Case Report
Acute Leukemia Initial Presentation as Acute Appendicitis - Case Reportasclepiuspdfs
 
Parent’s opinions on the diagnosis of children under 2 years of age with urin...
Parent’s opinions on the diagnosis of children under 2 years of age with urin...Parent’s opinions on the diagnosis of children under 2 years of age with urin...
Parent’s opinions on the diagnosis of children under 2 years of age with urin...Josep Vidal-Alaball
 
HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain Lifecare Centre
 
Cervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSACervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSADES Daughter
 
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain Lifecare Centre
 

What's hot (20)

Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...
Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...
Into the Vast Unknown: Early Lessons from a PrEP Demonstration Project in Cis...
 
Introducing HPV Vaccine
Introducing HPV VaccineIntroducing HPV Vaccine
Introducing HPV Vaccine
 
Shorter anogenital distance predicts poorer semen quality in young men in NY ...
Shorter anogenital distance predicts poorer semen quality in young men in NY ...Shorter anogenital distance predicts poorer semen quality in young men in NY ...
Shorter anogenital distance predicts poorer semen quality in young men in NY ...
 
Measuring effectiveness of the cervical cancer vaccine in an Australian setti...
Measuring effectiveness of the cervical cancer vaccine in an Australian setti...Measuring effectiveness of the cervical cancer vaccine in an Australian setti...
Measuring effectiveness of the cervical cancer vaccine in an Australian setti...
 
Diagnostic importance dna
Diagnostic importance dnaDiagnostic importance dna
Diagnostic importance dna
 
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...Mission SAY No to Cervical Cancer   With HPV Vaccination DR. SHARDA JAIN  S...
Mission SAY No to Cervical Cancer With HPV Vaccination DR. SHARDA JAIN S...
 
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
Effectiveness of Via and Vili as A Screening Tool for Cervical Intra Epitheli...
 
National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)
National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)
National Press Foundation - Understanding Vaccines (David Curry, Peg Willingham)
 
Women's Understanding of the term 'Pap Smear'
Women's Understanding of the term 'Pap Smear'Women's Understanding of the term 'Pap Smear'
Women's Understanding of the term 'Pap Smear'
 
Polymerase chain reaction
Polymerase chain reactionPolymerase chain reaction
Polymerase chain reaction
 
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
Post Partum Vaccination Dr. Jyoti Agarwal, Dr. Sharda jain
 
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
 
Acute Leukemia Initial Presentation as Acute Appendicitis - Case Report
Acute Leukemia Initial Presentation as Acute Appendicitis - Case ReportAcute Leukemia Initial Presentation as Acute Appendicitis - Case Report
Acute Leukemia Initial Presentation as Acute Appendicitis - Case Report
 
Parent’s opinions on the diagnosis of children under 2 years of age with urin...
Parent’s opinions on the diagnosis of children under 2 years of age with urin...Parent’s opinions on the diagnosis of children under 2 years of age with urin...
Parent’s opinions on the diagnosis of children under 2 years of age with urin...
 
Hvp vaccines
Hvp vaccinesHvp vaccines
Hvp vaccines
 
GENETICS
GENETICSGENETICS
GENETICS
 
HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain HPV Vaccination , Dr. Sharda Jain
HPV Vaccination , Dr. Sharda Jain
 
Cervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSACervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSA
 
Striving for Balance in Cancer Screening News
Striving for Balance in Cancer Screening News  Striving for Balance in Cancer Screening News
Striving for Balance in Cancer Screening News
 
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain
UPDATE HPV Vaccination IN Cervical Cancer Prevention Dr Sharda Jain
 

Viewers also liked

Ishimaru (Kodomomira)- Food safety after 311
Ishimaru (Kodomomira)- Food safety after 311Ishimaru (Kodomomira)- Food safety after 311
Ishimaru (Kodomomira)- Food safety after 311Safecast
 
Kalin Kozhuharov: Safecast 6D; Safecast symposium presentation
Kalin Kozhuharov: Safecast 6D; Safecast symposium presentationKalin Kozhuharov: Safecast 6D; Safecast symposium presentation
Kalin Kozhuharov: Safecast 6D; Safecast symposium presentationSafecast
 
Pieter Franken, Sean Bonner: Safecast Today and Tomorrow
Pieter Franken, Sean Bonner: Safecast Today and TomorrowPieter Franken, Sean Bonner: Safecast Today and Tomorrow
Pieter Franken, Sean Bonner: Safecast Today and TomorrowSafecast
 
Rob Oudendijk: Sensors for Fukushima Wheel
Rob Oudendijk: Sensors for Fukushima WheelRob Oudendijk: Sensors for Fukushima Wheel
Rob Oudendijk: Sensors for Fukushima WheelSafecast
 
Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...
Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...
Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...Safecast
 
Miles O'Brien and Joe Moross: Inside Daiichi
Miles O'Brien and Joe Moross: Inside DaiichiMiles O'Brien and Joe Moross: Inside Daiichi
Miles O'Brien and Joe Moross: Inside DaiichiSafecast
 
Kojima- Chernobyl Visit 2013
Kojima- Chernobyl Visit 2013Kojima- Chernobyl Visit 2013
Kojima- Chernobyl Visit 2013Safecast
 
Yamadera-Fukushima Wheel - Safecast
Yamadera-Fukushima Wheel -  SafecastYamadera-Fukushima Wheel -  Safecast
Yamadera-Fukushima Wheel - SafecastSafecast
 
Ken Buesseler - Fukushima - A view from the ocean
Ken Buesseler - Fukushima - A view from the oceanKen Buesseler - Fukushima - A view from the ocean
Ken Buesseler - Fukushima - A view from the oceanSafecast
 
Safecast presentation at Stanford Medicine X 2012
Safecast presentation at Stanford Medicine X 2012Safecast presentation at Stanford Medicine X 2012
Safecast presentation at Stanford Medicine X 2012Safecast
 
Safecast Report Vol. 2 - 2016 Executive Summary
Safecast Report Vol. 2 - 2016 Executive SummarySafecast Report Vol. 2 - 2016 Executive Summary
Safecast Report Vol. 2 - 2016 Executive SummarySafecast
 

Viewers also liked (11)

Ishimaru (Kodomomira)- Food safety after 311
Ishimaru (Kodomomira)- Food safety after 311Ishimaru (Kodomomira)- Food safety after 311
Ishimaru (Kodomomira)- Food safety after 311
 
Kalin Kozhuharov: Safecast 6D; Safecast symposium presentation
Kalin Kozhuharov: Safecast 6D; Safecast symposium presentationKalin Kozhuharov: Safecast 6D; Safecast symposium presentation
Kalin Kozhuharov: Safecast 6D; Safecast symposium presentation
 
Pieter Franken, Sean Bonner: Safecast Today and Tomorrow
Pieter Franken, Sean Bonner: Safecast Today and TomorrowPieter Franken, Sean Bonner: Safecast Today and Tomorrow
Pieter Franken, Sean Bonner: Safecast Today and Tomorrow
 
Rob Oudendijk: Sensors for Fukushima Wheel
Rob Oudendijk: Sensors for Fukushima WheelRob Oudendijk: Sensors for Fukushima Wheel
Rob Oudendijk: Sensors for Fukushima Wheel
 
Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...
Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...
Ishimaru (Kodomomirai): Why caesium is detected in food; Safecast symposium p...
 
Miles O'Brien and Joe Moross: Inside Daiichi
Miles O'Brien and Joe Moross: Inside DaiichiMiles O'Brien and Joe Moross: Inside Daiichi
Miles O'Brien and Joe Moross: Inside Daiichi
 
Kojima- Chernobyl Visit 2013
Kojima- Chernobyl Visit 2013Kojima- Chernobyl Visit 2013
Kojima- Chernobyl Visit 2013
 
Yamadera-Fukushima Wheel - Safecast
Yamadera-Fukushima Wheel -  SafecastYamadera-Fukushima Wheel -  Safecast
Yamadera-Fukushima Wheel - Safecast
 
Ken Buesseler - Fukushima - A view from the ocean
Ken Buesseler - Fukushima - A view from the oceanKen Buesseler - Fukushima - A view from the ocean
Ken Buesseler - Fukushima - A view from the ocean
 
Safecast presentation at Stanford Medicine X 2012
Safecast presentation at Stanford Medicine X 2012Safecast presentation at Stanford Medicine X 2012
Safecast presentation at Stanford Medicine X 2012
 
Safecast Report Vol. 2 - 2016 Executive Summary
Safecast Report Vol. 2 - 2016 Executive SummarySafecast Report Vol. 2 - 2016 Executive Summary
Safecast Report Vol. 2 - 2016 Executive Summary
 

Similar to Azby three-year symposium-health v06

Notes on Williams -Thyroid growth and cancer
Notes on Williams -Thyroid growth and cancerNotes on Williams -Thyroid growth and cancer
Notes on Williams -Thyroid growth and cancerAzby Brown
 
Descriptive epidemiology
Descriptive epidemiologyDescriptive epidemiology
Descriptive epidemiologyDalia El-Shafei
 
Update on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptUpdate on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptSyedaAyeshaFatima2
 
Human papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineHuman papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineKeith Wassung
 
마더세이프라운드 radiation dose[윤석남 교수]
마더세이프라운드 radiation dose[윤석남 교수]마더세이프라운드 radiation dose[윤석남 교수]
마더세이프라운드 radiation dose[윤석남 교수]mothersafe
 
Statistical quality control in cervical vaginal cythology: ASC-US/SIL Ratio
Statistical quality control in cervical vaginal cythology: ASC-US/SIL RatioStatistical quality control in cervical vaginal cythology: ASC-US/SIL Ratio
Statistical quality control in cervical vaginal cythology: ASC-US/SIL RatioRolando Alvarado Anchisi
 
Lapkas gizi
Lapkas giziLapkas gizi
Lapkas gizirinadels
 
Mammography Screening
Mammography ScreeningMammography Screening
Mammography ScreeningDES Daughter
 
Screening for breast cancer? A decision that belongs to every woman- Informat...
Screening for breast cancer? A decision that belongs to every woman- Informat...Screening for breast cancer? A decision that belongs to every woman- Informat...
Screening for breast cancer? A decision that belongs to every woman- Informat...Cancer Rose
 
screening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptxscreening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptxLeHaRe
 
Management and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxManagement and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxAmin Badamosi
 
Radiation and Medical Imaging
Radiation and Medical ImagingRadiation and Medical Imaging
Radiation and Medical ImagingBhavin Jankharia
 
Pap smear test
Pap smear testPap smear test
Pap smear testiangould64
 
2010 09-11 sparc vaccines
2010 09-11 sparc vaccines2010 09-11 sparc vaccines
2010 09-11 sparc vaccinesdrdavid999
 

Similar to Azby three-year symposium-health v06 (20)

Notes on Williams -Thyroid growth and cancer
Notes on Williams -Thyroid growth and cancerNotes on Williams -Thyroid growth and cancer
Notes on Williams -Thyroid growth and cancer
 
Descriptive epidemiology
Descriptive epidemiologyDescriptive epidemiology
Descriptive epidemiology
 
Update on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.pptUpdate on Cervical Cancer Screening Barb Apgar.ppt
Update on Cervical Cancer Screening Barb Apgar.ppt
 
Professor Soo Downe
Professor Soo DowneProfessor Soo Downe
Professor Soo Downe
 
Human papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) VaccineHuman papillomavirus (HPV) Vaccine
Human papillomavirus (HPV) Vaccine
 
마더세이프라운드 radiation dose[윤석남 교수]
마더세이프라운드 radiation dose[윤석남 교수]마더세이프라운드 radiation dose[윤석남 교수]
마더세이프라운드 radiation dose[윤석남 교수]
 
HINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based PracticeHINZ Education Workshop: Evidence Based Practice
HINZ Education Workshop: Evidence Based Practice
 
Statistical quality control in cervical vaginal cythology: ASC-US/SIL Ratio
Statistical quality control in cervical vaginal cythology: ASC-US/SIL RatioStatistical quality control in cervical vaginal cythology: ASC-US/SIL Ratio
Statistical quality control in cervical vaginal cythology: ASC-US/SIL Ratio
 
Lapkas gizi
Lapkas giziLapkas gizi
Lapkas gizi
 
Xylometazoline (Nasal Decongestant
Xylometazoline (Nasal DecongestantXylometazoline (Nasal Decongestant
Xylometazoline (Nasal Decongestant
 
Mammography Screening
Mammography ScreeningMammography Screening
Mammography Screening
 
Screening for breast cancer? A decision that belongs to every woman- Informat...
Screening for breast cancer? A decision that belongs to every woman- Informat...Screening for breast cancer? A decision that belongs to every woman- Informat...
Screening for breast cancer? A decision that belongs to every woman- Informat...
 
Cancer
Cancer Cancer
Cancer
 
Genetic counseling
Genetic counselingGenetic counseling
Genetic counseling
 
1 sk jain 2 rev
1 sk jain 2 rev1 sk jain 2 rev
1 sk jain 2 rev
 
screening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptxscreening and diagnostic methods SSS.pptx
screening and diagnostic methods SSS.pptx
 
Management and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptxManagement and prevention of cervical cancer.pptx
Management and prevention of cervical cancer.pptx
 
Radiation and Medical Imaging
Radiation and Medical ImagingRadiation and Medical Imaging
Radiation and Medical Imaging
 
Pap smear test
Pap smear testPap smear test
Pap smear test
 
2010 09-11 sparc vaccines
2010 09-11 sparc vaccines2010 09-11 sparc vaccines
2010 09-11 sparc vaccines
 

More from Safecast

Safecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-final
Safecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-finalSafecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-final
Safecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-finalSafecast
 
Safecast Report 2016 Japanese all v02
Safecast Report 2016 Japanese all v02Safecast Report 2016 Japanese all v02
Safecast Report 2016 Japanese all v02Safecast
 
Safecast Report 2017 - Part 1 Safecast Project- Final
Safecast Report 2017 - Part 1 Safecast Project- FinalSafecast Report 2017 - Part 1 Safecast Project- Final
Safecast Report 2017 - Part 1 Safecast Project- FinalSafecast
 
Better Than A Bag Of Bricks
Better Than A Bag Of BricksBetter Than A Bag Of Bricks
Better Than A Bag Of BricksSafecast
 
Owod 05-3-sean+pieter-solarcast
Owod 05-3-sean+pieter-solarcastOwod 05-3-sean+pieter-solarcast
Owod 05-3-sean+pieter-solarcastSafecast
 
Owod 05-1-jay patel-nonexistent_data
Owod 05-1-jay patel-nonexistent_dataOwod 05-1-jay patel-nonexistent_data
Owod 05-1-jay patel-nonexistent_dataSafecast
 
Owod 04-3-kiyoshi kurokawa
Owod 04-3-kiyoshi kurokawaOwod 04-3-kiyoshi kurokawa
Owod 04-3-kiyoshi kurokawaSafecast
 
Owpd 04-2-madeleine ball our world our data
Owpd 04-2-madeleine ball our world our dataOwpd 04-2-madeleine ball our world our data
Owpd 04-2-madeleine ball our world our dataSafecast
 
Owpd 04-1-denice ross-owod
Owpd 04-1-denice ross-owodOwpd 04-1-denice ross-owod
Owpd 04-1-denice ross-owodSafecast
 
Owod 03-3-azby brown - obscure data
Owod 03-3-azby brown - obscure dataOwod 03-3-azby brown - obscure data
Owod 03-3-azby brown - obscure dataSafecast
 
Owod 03-2-abhijit rs data - obscurity to insight
Owod 03-2-abhijit rs data - obscurity to insightOwod 03-2-abhijit rs data - obscurity to insight
Owod 03-2-abhijit rs data - obscurity to insightSafecast
 
Owpd 03-1-daniel lombraña obscure-data
Owpd 03-1-daniel lombraña obscure-dataOwpd 03-1-daniel lombraña obscure-data
Owpd 03-1-daniel lombraña obscure-dataSafecast
 
Owod 02-3-sean bonner-govt data
Owod 02-3-sean bonner-govt dataOwod 02-3-sean bonner-govt data
Owod 02-3-sean bonner-govt dataSafecast
 
Owod 02-1-natalie harris government data
Owod 02-1-natalie harris government dataOwod 02-1-natalie harris government data
Owod 02-1-natalie harris government dataSafecast
 
Owod 01-3-pieter franken - corporate data
Owod 01-3-pieter franken - corporate dataOwod 01-3-pieter franken - corporate data
Owod 01-3-pieter franken - corporate dataSafecast
 
Owod 01-2-andrew young-corporatedata
Owod 01-2-andrew young-corporatedataOwod 01-2-andrew young-corporatedata
Owod 01-2-andrew young-corporatedataSafecast
 
Owod 01-1-mmckinzie 30april owod
Owod 01-1-mmckinzie 30april owodOwod 01-1-mmckinzie 30april owod
Owod 01-1-mmckinzie 30april owodSafecast
 
Safecast- The Next Five Years
Safecast- The Next Five YearsSafecast- The Next Five Years
Safecast- The Next Five YearsSafecast
 
Safecast Report 2016 final01-print
Safecast Report 2016 final01-printSafecast Report 2016 final01-print
Safecast Report 2016 final01-printSafecast
 
ACCJ - Safecast March 2016
ACCJ - Safecast March 2016ACCJ - Safecast March 2016
ACCJ - Safecast March 2016Safecast
 

More from Safecast (20)

Safecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-final
Safecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-finalSafecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-final
Safecast Report2017: Part 2.1-Issues-at-Fukushima-Daiichi-final
 
Safecast Report 2016 Japanese all v02
Safecast Report 2016 Japanese all v02Safecast Report 2016 Japanese all v02
Safecast Report 2016 Japanese all v02
 
Safecast Report 2017 - Part 1 Safecast Project- Final
Safecast Report 2017 - Part 1 Safecast Project- FinalSafecast Report 2017 - Part 1 Safecast Project- Final
Safecast Report 2017 - Part 1 Safecast Project- Final
 
Better Than A Bag Of Bricks
Better Than A Bag Of BricksBetter Than A Bag Of Bricks
Better Than A Bag Of Bricks
 
Owod 05-3-sean+pieter-solarcast
Owod 05-3-sean+pieter-solarcastOwod 05-3-sean+pieter-solarcast
Owod 05-3-sean+pieter-solarcast
 
Owod 05-1-jay patel-nonexistent_data
Owod 05-1-jay patel-nonexistent_dataOwod 05-1-jay patel-nonexistent_data
Owod 05-1-jay patel-nonexistent_data
 
Owod 04-3-kiyoshi kurokawa
Owod 04-3-kiyoshi kurokawaOwod 04-3-kiyoshi kurokawa
Owod 04-3-kiyoshi kurokawa
 
Owpd 04-2-madeleine ball our world our data
Owpd 04-2-madeleine ball our world our dataOwpd 04-2-madeleine ball our world our data
Owpd 04-2-madeleine ball our world our data
 
Owpd 04-1-denice ross-owod
Owpd 04-1-denice ross-owodOwpd 04-1-denice ross-owod
Owpd 04-1-denice ross-owod
 
Owod 03-3-azby brown - obscure data
Owod 03-3-azby brown - obscure dataOwod 03-3-azby brown - obscure data
Owod 03-3-azby brown - obscure data
 
Owod 03-2-abhijit rs data - obscurity to insight
Owod 03-2-abhijit rs data - obscurity to insightOwod 03-2-abhijit rs data - obscurity to insight
Owod 03-2-abhijit rs data - obscurity to insight
 
Owpd 03-1-daniel lombraña obscure-data
Owpd 03-1-daniel lombraña obscure-dataOwpd 03-1-daniel lombraña obscure-data
Owpd 03-1-daniel lombraña obscure-data
 
Owod 02-3-sean bonner-govt data
Owod 02-3-sean bonner-govt dataOwod 02-3-sean bonner-govt data
Owod 02-3-sean bonner-govt data
 
Owod 02-1-natalie harris government data
Owod 02-1-natalie harris government dataOwod 02-1-natalie harris government data
Owod 02-1-natalie harris government data
 
Owod 01-3-pieter franken - corporate data
Owod 01-3-pieter franken - corporate dataOwod 01-3-pieter franken - corporate data
Owod 01-3-pieter franken - corporate data
 
Owod 01-2-andrew young-corporatedata
Owod 01-2-andrew young-corporatedataOwod 01-2-andrew young-corporatedata
Owod 01-2-andrew young-corporatedata
 
Owod 01-1-mmckinzie 30april owod
Owod 01-1-mmckinzie 30april owodOwod 01-1-mmckinzie 30april owod
Owod 01-1-mmckinzie 30april owod
 
Safecast- The Next Five Years
Safecast- The Next Five YearsSafecast- The Next Five Years
Safecast- The Next Five Years
 
Safecast Report 2016 final01-print
Safecast Report 2016 final01-printSafecast Report 2016 final01-print
Safecast Report 2016 final01-print
 
ACCJ - Safecast March 2016
ACCJ - Safecast March 2016ACCJ - Safecast March 2016
ACCJ - Safecast March 2016
 

Recently uploaded

Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Neo4j
 
APIForce Zurich 5 April Automation LPDG
APIForce Zurich 5 April  Automation LPDGAPIForce Zurich 5 April  Automation LPDG
APIForce Zurich 5 April Automation LPDGMarianaLemus7
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
 
costume and set research powerpoint presentation
costume and set research powerpoint presentationcostume and set research powerpoint presentation
costume and set research powerpoint presentationphoebematthew05
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024Scott Keck-Warren
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsMemoori
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Mark Simos
 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions
 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024The Digital Insurer
 
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024BookNet Canada
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Enterprise Knowledge
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebUiPathCommunity
 
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks..."LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...Fwdays
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii SoldatenkoFwdays
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machinePadma Pradeep
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...shyamraj55
 

Recently uploaded (20)

Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024Build your next Gen AI Breakthrough - April 2024
Build your next Gen AI Breakthrough - April 2024
 
APIForce Zurich 5 April Automation LPDG
APIForce Zurich 5 April  Automation LPDGAPIForce Zurich 5 April  Automation LPDG
APIForce Zurich 5 April Automation LPDG
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
 
costume and set research powerpoint presentation
costume and set research powerpoint presentationcostume and set research powerpoint presentation
costume and set research powerpoint presentation
 
SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024SQL Database Design For Developers at php[tek] 2024
SQL Database Design For Developers at php[tek] 2024
 
AI as an Interface for Commercial Buildings
AI as an Interface for Commercial BuildingsAI as an Interface for Commercial Buildings
AI as an Interface for Commercial Buildings
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
 
Pigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food ManufacturingPigging Solutions in Pet Food Manufacturing
Pigging Solutions in Pet Food Manufacturing
 
My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024My INSURER PTE LTD - Insurtech Innovation Award 2024
My INSURER PTE LTD - Insurtech Innovation Award 2024
 
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
New from BookNet Canada for 2024: BNC BiblioShare - Tech Forum 2024
 
Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024Designing IA for AI - Information Architecture Conference 2024
Designing IA for AI - Information Architecture Conference 2024
 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio Web
 
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks..."LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
"LLMs for Python Engineers: Advanced Data Analysis and Semantic Kernel",Oleks...
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
 
Install Stable Diffusion in windows machine
Install Stable Diffusion in windows machineInstall Stable Diffusion in windows machine
Install Stable Diffusion in windows machine
 
DMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special EditionDMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special Edition
 
Hot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort Service
Hot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort ServiceHot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort Service
Hot Sexy call girls in Panjabi Bagh 🔝 9953056974 🔝 Delhi escort Service
 
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
 

Azby three-year symposium-health v06

  • 1. HEALTH (This is an expanded version of a talk given at the Fukushima:The Next ThreeYears symposium in Tokyo, March 15, 2014) Azby Brown, SAFECAST v06
  • 2. Lots of potential health consequences = Lots of concerns Thyroid cancer, leukemia, other cancer, birth effects, other disease, DNA mutations? Food, water, playing outside, pregnancy?
  • 3. Legitimate grievances Is the Gov’t doing everything it can to ensure our health and safety? Is justice being done, in terms of compensation, accountability, etc? How can people be compensated for such massive damage to their lives anyway?
  • 4. Uncertainty It is almost always impossible to say conclusively how many people will get sick. Estimates are almost always based on incomplete information.
  • 5. Uncertainty But even with good data we’re usually left with no more than a “range of probability.” --Depending on the type of data and its quality, uncertainty might be small i.e., +/- 10%. --In our current situation, it’s rarely less than a factor of 2, i.e. +/- 2x --In many cases, it’s an order of magnitude or more, i.e. +/-10x. This is actually normal.
  • 6. Uncertainty • So, expert A says “Probably 2.5% will get sick.” • Expert B says,“Probably 5% will get sick.” • Expert B’s estimate is double expert A’s. • But actually they agree closely.
  • 7. “Essentially, all models are wrong, but some are useful.” “Remember that all models are wrong; the practical question is how wrong do they have to be to not be useful.” George E.P. Box MODELS:
  • 8. immediate (acute) effects long-term (stochastic) effects begin to see ARS 50% fatal in 1 month fatal in weeks 1 Sv=1000 mSv: increased risk of fatal cancer 5% (but good arguments for assuming 10%) good (but not conclusive) evidence for increased leukemia 0 mSv 20 100 1000 5000 10,000 increased cancer % is clearuse LNT
  • 9. immediate (acute) effects long-term (stochastic) effects begin to see ARS 50% fatal in 1 month fatal in weeks 1 Sv=1000 mSv: increased risk of fatal cancer 5% (but good arguments for assuming 10%) good (but not conclusive) evidence for increased leukemia 0 mSv 20 100 1000 5000 10,000 increased cancer % is clearuse LNT Best Fukushima dose estimates
  • 10. Dumb Luck. The wind usually blew the plume out to sea. That’s the main reason the doses are so low.
  • 11. About “dose” and “risk” 5% per Sv? 10% per Sv? Public health risk: Increased fatal cancer risk: Individual risk: 100mSv = 0.5 -1% 10mSv= 0.05-0.1% 1mSv= 0.005- 0.01% 100mSv = 5-10 per 1000 pers 10mSv = 5-10 per 10,000 pers 1mSv = 5-10 per 100,000 pers Current assumption: Some evidence suggests:
  • 12. Measurement (“in-vivo”) Based on WBC, blood tests, personal dosimetry, etc. Estimates (reconstruction, simulation) Based on environmental dose rates, models, food intake surveys, etc. Epidemiology (past experience, statistics) Based on historical statistics, etc. Less uncertainty More uncertainty It’s very important to have good in-vivo measurements!
  • 13. Some things we’ll never know for sure: Initial doses, i.e March-May, 2011 Not enough in-vivo screening was done! (But maybe enough to make acceptable estimates)
  • 14. Psycho-social effects Very real, very serious already Stress, PTSD, depression, sleep disorders, chronic anxiety, physical symptoms, family problems, breakdown of community support, etc. Already 1,660 “disaster-related deaths” in Fukushima! (i.e. life shortened by stress of evacuation)
  • 16. Fukushima Prefecture Health Survey thyroid screening program Total screened to date (age 0-18): 269,354 (out of 333,403 planned in 1st round of screening) Anomalies (nodules/cysts found): 46.6% Cancers found or suspected: 74 cases (0.027%) What does this mean?
  • 17. Opinions of outside experts: Sir Dillwyn Williams, Cambridge Univ. : (A leading endocrinologist who, with, Keith Baverstock, made a crucial effort to get thyroid cancer outbreak acknowledged after Chernobyl) --The observed incidence of any cancer in a population depends on the method used to look for it. --Any systematic survey will find more cases than the normal system of waiting for the patient or relatives to notice something. --The more sensitive the screening system the larger number of cases will be found. --This is particularly true for slow growing cancers like thyroid, where it takes a considerable time for the earliest cancer to grow from just a few cells to a detectable lump. He points out that: (personal communication)
  • 18. Sir Dillwyn Williams, cont’d - The chance that the current apparent increase in thyroid tumours is due to radiation exposure is very low. - The tumors pose little health threat. - High-resolution ultrasound screening is a new technique, and reveals many harmless anomalies. - Not enough time has passed for radiogenic tumors to appear. - The doses are uncertain, but appear too low in nearly all areas to cause detectable increase. - Milk and other contaminated food was stopped soon. - Japanese children have sufficient iodine in their diet compared to Chernobyl. - This study will show the normal baseline prevalence of thyroid tumors. - It’s too early to know for sure how many new cases will arise (incidence), we will have to wait at least 4 years. Initial opinion in Feb., 2012: (personal communication)
  • 19. As more data became available, similar opinions expressed by Baverstock, Demidchik,Tronko, Ivanov, Jacob, and other leading experts: Fukushima thyroid cancers, so far (Feb. 2014): - Still to soon to be caused by radiation. - Children under 5 would be first, but none so far. - No clear correlation with dose levels “It’s still too early to know.” But we can expect some increase ! At this point, strong consensus.
  • 20. 31 December 2013) 2.2.1 Suspicious or malignant cases by age as of 11 March 2011 2.2.2 Suspicious or malignant cases by age as of the date of confirmatory examination 0 2 4 6 8 10 12 14 16 18 20 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Female Male Number Age Number Fukushima Health Management Survey, Reported on 7 February 2014 None under 5yrs
  • 21. “Dissenting” viewpoint: Tsuda, Hamaoka, etc.: - Rate seems to be increasing 2011-2013. - Maybe there is a correlation with dose levels. - Maybe Chernobyl tumors would have been detected. earlier if there had been widespread ultrasound screening. - Maybe Fukushima dosimetry is very wrong. - Maybe Fukushima Pref Health Survey is untrustworthy. The evidence is not strong, but these ideas need to be considered and tested! Good scientists never say “never” !
  • 22. Results of thyroid comparison survey Dates of study: Nov, 2012 - March 2013 4365 children in Aomori Pref., Yamanashi Pref., Nagasaki Pref. Age 3-18 years Anomaly detection rate: 56.88% (Detection rate in Fukushima: 43.6%) Source: Japan Environ. Ministry: http://www.env.go.jp/press/press.php?serial=16419 More anomalies outside Fukushima The results are similar, but the surveys are not perfectly comparable, and the size of the cohort is statistically very small; one more cancer case would double the apparent rate. Preliminary report March, 2013; Detailed report, Hayashida, et al, Dec., 2013 UPDATE: March 28, 2014: Results of followup examinations: --31 children had followup exams. --1 cancer case found or suspected. --The rate so far is 0.022% ; the rate in Fukushima is 0.027% (but actually quite similar)
  • 23. What do we know about the thyroid doses? Unfortunately, not many timely in-vivo measurements, and it’s difficult to be confident in the results: Hosokawa, et al: 1080 children in Iitate, Kawamata, Iwaki: avg 12mSv, max 42 mSv Tokonami, et al: 62 pers 0-83 yrs: Children: median 4.2 mSv, max 23 mSv Adults: median 3.5 mSv, max 33 mSv (About 400,000 people were screened a short time after the Chernobyl disaster!) Also some data from US military, overseas embassies.
  • 24. These match the most thorough independent dose reconstruction for Iitate (Imanaka): --1yr old: min 14mSv, avg 24mSv, max 55mSv Though these reconstructions match well, the initial doses are still uncertain. What do we know about the thyroid doses? WHO estimates, 2013: --Iitate: 1yr old: 73mSv --Namie: 1yr old: 122mSv (Assumed outdoors 24 hrs/day, and ate contaminated food) UNSCEAR, 2013: --All Fukushima: 1yr old: avg 15-83mSv --Iitate: 1yr old: avg 56mSv --Maximum estimated dose: 150 mSv
  • 25. !"#"$%&% !" '%()*) +,*&"#*- #$%&' .%/(&"0000000 () '%()*) +,*&"#*- )*"%&' 12"345"6" +,) '%()*) +,*&"#*- ,*)%&' 142"2*0,477"#*00000 +-!".'%()*) +,*&"#*- +#%&' Imanaka, 2013
  • 26. 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 mSv WHO: UNSCEAR: children children Iitate 1yr old Imanaka: Iitate 1yr old !"#$#%&$'(&)*+&,-. All Fukushima 1yr olds Namie1yr old adults /01023"4$&#3*+,".&.,2%25&)2#&*%$+5&6%2#&%2#"4$#%2 78$"+-*&9-,2%&$(+%%4%:#5&4$;&)<=&4>'? $'(@4%$: 7:,&$'(@4%$:&("'%:? !:A'"',&4%$20+%4%:#2 B,2%& +%9,:2#+09#",:2 7+$:(%&,8&$'%+$(%2&,8&$--&2%##-%4%:#2? 7+$:(%&,8&0:9%+#$":#*? Hosokawa, et al: Tokonami, et al:
  • 27. Rayon-average thyroid doses of children and adolescents (as of time of the Chernobyl accident) in Belarus, Russia and Ukraine (Ivanov, Kenigsberg, Likhtarev, Balonov, 2006) All rights reserved >650 mGy 150-650 mGy 30-150 mGy 10-30 mGy Quite a few over 1 Gy!(1Gy≈1Sv)
  • 28. Chernobyl thyroid doses: up to 1000mSv + Fukushima thyroid dose estimates (But some cancers expected at low dose range) 1000 200 300 400 500 600 700 800 900 1000 mSv 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 mSv WHO: UNSCEAR: children children Iitate 1yr old Imanaka: Iitate 1yr old !"#$#%&$'(&)*+&,-. All Fukushima 1yr olds Namie1yr old adults /01023"4$&#3*+,".&.,2%25&)2#&*%$+5&6%2#&%2#"4$#%2 78$"+-*&9-,2%&$(+%%4%:#5&4$;&)<=&4>'? $'(@4%$: 7:,&$'(@4%$:&("'%:? !:A'"',&4%$20+%4%:#2 B,2%& +%9,:2#+09#",:2 7+$:(%&,8&$'%+$(%2&,8&$--&2%##-%4%:#2? 7+$:(%&,8&0:9%+#$":#*? Hosokawa, et al: Tokonami, et al:
  • 29. How much thyroid cancer are we likely to see? One reasonable estimate so far: Many uncertainties, not conclusive! Jacob, et al, 2014: --New baseline (normal prevalence) will be about 7x higher than previously believed, i.e., 2.2%. --Based on the estimated percentages, in the next 50 years, with 330,000 people being studied, about 7300 will be diagnosed with thyroid cancer. --Only about 300-1000 of these will be new cases (incidence) due to radiation. --Most of these would not cause health problems if not discovered (i.e. they would be “subclinical”).
  • 30. Pros and Cons of thyroid screening according to Williams: Pros: --Screening reassures the great majority of the population that they do not have a cancer. --Resection of screen detected tumors in children may prevent the development of ‘more difficult to treat’ cancers at a later age. Cons: --Screening raises the level of concern in the population generally. --Some, possibly many, of the operations may have been for ‘technical cancers’ which would not have progressed. --Operations carry a risk of complications, even though these are extremely rare in skilled hands. (personal communication)
  • 31. Will the Fukushima thyroid screening program create more health problems than it solves? “It was appropriate to set up the screening program for those exposed to Fukushima fallout; on balance I believe it will benefit the population as well as providing information that will be very important in the event of another accident. Open discussions with the public to consider all the results and decide on the appropriate future course of action are extremely important.” Williams suggests that: (personal communication)
  • 32. So far, most experts generally agree with the interpretation of thyroid screening results stated by the gov’t, but many people do not believe them.
  • 33. Legitimate grievances --Very poor communication, gov’t did not manage expectations. -- Misleading statements by Dr.Yamashita (“No risk below 100 mSv”). -- Many people feel the emphasis has been on “collecting data” rather than on providing “health care.”
  • 34. What can be done to improve the credibility of health screening? --Involve independent, 3rd-party groups, individuals, in setting study parameters. --Involve independent monitors for studies themselves, and analysis of results. --Include “dissenters” in all important conferences, meetings. Improve transparency!
  • 35. The problems that have arisen concerning this thyroid screening program should cause us to re-examine how such programs can best be implemented.  --Screening should be restricted to those under age 14 at exposure. --Should be limited to areas with estimated average infant thyroid doses of more than 10mGy. --Screening should be offered on an individual basis, with an explanation of the risks and benefits. --Resection should continue to be advised for screening-detected cancers in children as we cannot currently distinguish those that will progress from those that will not. (personal communication) Williams' provisional suggestions include:
  • 36. Other screening, monitoring Internal contamination screening done using whole body counters (WBC) --Fukushima Prefecture: Results very incompletely reported! --Local governments (Minamisoma, Hirata, Soma, etc): Often most complete, accurate surveys --NPOs (CRMS, others): Wide range in quality, completeness. But basically, results are similar
  • 37. WBC Screening program administered by Fukushima Prefecture
  • 38. Total screened to date Period ending Jan., 2014 Fukushima Prefecture Internal Contamination Screening (WBC) Total screened this period Below 1mSv/yr (99%) 1mSv/yr 2 mSv/yr 3 mSv/yr -- No distribution by Bq/body is given! (But data probably exists) -- No information given about % which were below detection level (ND) -- People were not weighed, so it will be impossible to know distributions by Bq/kg! Over 99% less than 1mSv to date
  • 39. WBC Screening programs administered by Municipal Governments Since 2011, municipal governments such as Minamisoma and Hirata have taken the lead in providing well-planned and well-run WBC screening programs, under the guidance of Dr. Ryugo Hayano and Dr. Masaharu Tsubokura of Tokyo University. Their results are also the most completely and informatively published, and have withstood repeated peer-review. Gradually other local governments, such as Soma, Iwaki, and Kawachimura, have begun to adopt similar standards.
  • 40. WBC Screening programs administered by Municipal Governments Among the important features of these surveys are: --Repeated testing of residents to assess changes over time and effectiveness of interventions. --Families measured together whenever possible. --One-to-one counseling after tests. --Development of new technologies for accurately measuring infants and small children (“BabyScan”). --Clear demographic breakdowns of results by age, gender, etc.. --Examine correlations between sources of food, drinking water etc.. and internal contamination levels. --Excellent graphs and visualizations, as well as internet blogs to explain results.
  • 41. In late 2011, almost 40% of children in Minamisoma had internal contamination above a detection limit of 250 Bq/ body.Their initial doses shortly after the accident can only be estimated because WBC devices were not available.
  • 42. The detection rate declined throughout 2012, and effectively reached zero (though a 20kg child could still have as much as 12 Bq/kg and not be detected)
  • 43. By late 2013, largely due to effective counseling about food sources, the detection rate for adults also approached zero. MINAMISOMA CITY, April-Sept 2013 WBC results for adults (n=5810) (Canberra FastScan) Cs137, DL= 250 Bq/body Source: Minamisoma Municipal Hospital persons Cs, Bq/kg ND=98% Over 20Bq/kg=0.04%
  • 44. MINAMISOMA CITY, April-Sept 2013 WBC results for children (n=3390) (Canberra FastScan) Cs137, DL= 250 Bq/body Source: Minamisoma City persons Cs, Bq/kg ND=99.9% Over 20Bq/kg=0.0% Late 2013, detection rates in children remained effectively zero.
  • 45. Detection rates for both adults and children in Minamisoma are basically zero at present, but keeping them low will require continual monitoring and counseling. %detected Adults Children Minamisoma: Monthly Cs detection rates, 2011-2013 Source: Minamisoma City
  • 46. While detection rates have declined overall, 33 people who were “ND” at the 1st screening showed internal Cs at the second, and 22 had Cs at both screenings despite counseling. All are elderly who find it difficult to change their eating habits. Cs137 ; 2380 pers total Minamisoma: Changes observed in successive WBC screenings 1st screening 2nd screening Cs137 DETECTED Cs137 NOT DETECTED No. of pers. Source: Minamisoma City
  • 47. The results in Hirata City are similar. Detection rates were low overall in late 2011- early 2012.
  • 48. The detection rate for children during the same period was about 1%. This trend has continued. (Again, a 20kg child could have as much as 12 Bq/kg and not be detected.)
  • 49. Results have been consistent in most municipalities with similar screening and counseling programs.
  • 50. These municipalities usually provide useful breakdowns to help inform people which groups have the highest risk.
  • 51. WBC Screening programs administered by citizens’ groups
  • 52. Independent WBC screening report NPO CRMS Fukushima, Jan. 2014 Bq/kg Period Oct. 2011 - Dec. 2013 Over 80% ND Very few over 10Bq/kg (But detection level varied and is sometimes unclear) n= 5042 persons
  • 53. How do these results compare with the experience after Chernobyl?
  • 54. R 2929 Zvnova et al. Radiation Protection Dosimetry 2000 Minenko et.al Health Physics 2006 100,000 Bq/body 300,000 Bq/body Low average levels after several years: 10,000-20,000 Bq/body In most areas of Chernobyl, internal contamination was many times higher than what’s been found so far in Fukushima.
  • 55. Average internal contamination was between 20-40 Bq/kg 10-20 years after Chernobyl accident! (So far in Fukushima, very few people have been found with more than 10 Bq/kg) Avg. range
  • 56. Though their reliability and transparency differ, prefectural, municipal, and independent tests all indicate that internal contamination of Fukushima residents is many times lower than in Chernobyl. (peak levels as much as 1 order of magnitude lower, avg. levels 2 orders of magnitude lower) Food screening results, both official and independent, reinforce this conclusion. Nevertheless,“outliers” with higher contamination levels are still found.
  • 57. Strongest critique of WBC testing: --Lower levels can be detected by urine tests, WBC can’t detect Sr90, etc. Counter critique: --Urine tests error-prone, difficult to collect, unsuitable for mass screening. Sr90 doses can be estimated from known ratios. WBC alone is inadequate to give “clean bill of health.” Regular health checks of many types are needed. WBC can reliably show whether internal doses are greater than the 0.01 - 0.1mSv/year range.
  • 58. It will never be possible to have a perfect assurance of “no negative health effects” no matter what kind of testing is done. This is true always, even without radiation!
  • 59. Legitimate grievances People have a right to uncontaminated food; a right to demand 0 Bq/body from cesium. The environment and farmland will be contaminated for decades; will it really be possible to continue adequate food and internal contamination screening the whole time?
  • 60. !"#$%&"'(")*+,-(*+)./,0,1+&2*+,033(44,53$("3(,5&6%3(!"##"$!! %&&'())***+,%-./0123+1,&)4.1&,1&)5)5)6 only hope would have been time, the time it would take for the natural elimination of 137Cs from the ecosystem. And time is not an ally. While the half-life of 137Cs in ag- ricultural products is 2.8–5.6 years, it is approximately 10 years for berries and 20 years for mushrooms [11]. Fes- enko, et al.[12] studied twenty-seven rural settlements to assess the effectiveness of countermeasures. They ob- served an initial decrease of up to 40% of doses with a gradual diminution of effect over time. was accompanied by high unemployment and economic hardship, led to a reversion to traditional diets. People were forced to once again consume more locally produced food as well as "free" natural foods from the forests (mushrooms, berries, wild game, etc.). Moreover, after a relatively short period of time, it is likely that people be- came indifferent to warnings of the possible harm from radiation and to recommendations about the consump- tion of these foods. The influence of these factors is espe- Figure 3 Dynamics of annual effective doses of internal exposure (Dint) due to 137Cs ingestion in Rokitnovsky Rayon and selected vil- lage, Rivno Oblast, Ukraine by year from Whole Body Count (WBC) data 0.00 1.00 2.00 3.00 4.00 5.00 6.00 7.00 8.00 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 years AnnualdoseDint,mSv Rokitnovsky rayon Perehodichi Vezhytsia St. Selo Drozdyn After Chernobyl, internal doses decreased until 1990-91, then increased again as food screening was cut back. This is probably the greatest future risk for Fukushima residents in terms of internal contamination.
  • 62. Individual exposures can be assessed by giving each person a personal dosimeter (“glass badge”) --Virtually every municipality in Fukushima has done many glass badge surveys since 2011, involving large proportions of the population. --Results consistently show actual received doses to be much lower than estimates based on environmental dose rates and models (usually half or less). Again, inconsistent technically and in how reported; no independent oversight. Personal dosimetry (glass badge)
  • 63. ガラスバッジの結果 Glass badge results, 2011 福島市 伊達市 二本松市 郡山市 南相馬市 相馬市 注:各市HP掲載データをもとに,1年分に変換 1mSv/y 1mSv/y Data from thousands of individuals from many towns in 2011 showed that the majority of external exposures were already under 2 mSv/yr. (data from individual towns, graphed by R. Hayano)
  • 64. Fukushima City “glass badge” results, 2011 Fukushima City“glass badge”results, 2011 51% less than 1mSv/yr 36,767 persons totalDistribution of yearly exposure estimates yearly exposure (mSv/yr) Data from Fukushima City Gov’t Doses measured for 3 months, extrapolated to 1 year. 20 mSv/yr level no.ofpers 36,767 children and pregnant women living in Fukushima City were given personal dosimeters in Oct-Dec. 2011. Less than half had additional external exposures over 1mSv/yr. A few children receiving doses far above average, and the causes, were also identified. (In most cases the highest dose records were from people who left their badges outdoors for long periods, or allowed them to go through an airport Xray machine.)
  • 65. Fukushima City “glass badge” results, 2012 16,223 children under middle-school age were again given glass badges to wear from Nov. 2012 to Jan. 2013. Results showed that 88.7% had additional exposures below 1mSv/yr, a sharp decline in doses compared to the previous year. Distribution of yearly external exposure estimates 16,223 persons total Data from Fukushima City Gov’t 88.7% less than 1mSv/yr yearly exposure (mSv/yr) Doses measured for 3 months, extrapolated to 1 year. no.ofpers
  • 66. The doses showed a modest decline the following year, based on data from 10,100 children given glass badges from Sept. to Nov., 2013. Of these, 93.48% had additional exposures below 1mSv/yr, and no child received an exposure above 5mSv/yr. Fukushima City “glass badge” results, 2013 Distribution of yearly exposure estimates 10,100 persons total Data from Fukushima City Gov’t 93.48% less than 1mSv/yr yearly exposure (mSv/yr) Doses measured for 3 months, extrapolated to 1 year. 20 mSv, the level not to be exceeded according to ICRP 1990 no.ofpers
  • 67. ! " # $ % & 0.0 0.5 1.0 1.5 !"#$%&#'!($')*+#',%-#( ."/0)' '()*+,#-,'.**/0)+1.2,3/+4//2,51*,6.7/,8)+/,)29,522:)0,5991+1.2)0,;<=.7:*/,6.7/,, >,)+,)00,)?/7,@''' ABCDEFG, 500,5?/7, ;7+1B)+/9,H1?:*/, 522:)0,, 5991+1.2)0,, ;<=.7:*/,, 6.7/, , $ % & , '()*+,$-,'.**/0)+1.2,3/+4//2,51*,6.7/,8)+/,)29,522:)0,)991+1.2)0,/<=.7:*/,9.7/, >,5?/,!I"&,@, ;7+1B)+/9,H1?:*/, 522:)0,, 5991+1.2)0,, ;<=.7:*/,, Date City Glass Badge Results 52,783 pers, July 2012- June 2013 (Based on environmental dose rate) (Actual dosimetry) --Results show that 66% of residents’ additional external exposure is less than 1 mSv/yr --94% are less than 2 mSv/yr --76 persons are are over 5 mSv/yr --No child’s dose exceeded 4 mSv/yr (Data from Date City Govt)
  • 68. Personal dosimeters are available which can provide a good record of how exposures change from hour-to-hour. This is very useful for identifying the locations where the highest exposures are received, so decontamination can be effectively targeted and residents can avoid those locations. This requires people to sit down and counsel every resident, but unfortunately there are not enough staff for this at present!
  • 70. In conclusion, citizens have many legitimate grievances about health testing programs, and independent oversight is still lacking. Lack of trust causes people to doubt even reliable data and conclusions.The health risks from the Fukushima NPP accident will never be zero. Nevertheless the best screening and research to date suggest that an outbreak of radiation-induced thyroid cancer is unlikely, and that additional internal and external doses can be kept below 1mSv/yr for the vast majority of the population.
  • 71. This may not be “safe enough” in the eyes of many citizens, but it is realistic. To achieve and maintain even this, however, will require a long-term commitment on the part of the government to conscientious, well managed monitoring of the environment, food, and health. If past experience is any guide, we can’t assume that this will happen. Citizens should continue their efforts to gather and share information, and to press for independent oversight where needed.
  • 72. END